國家衛生研究院 NHRI:Item 3990099045/12750

NHRI > National Institute of Infectious Diseases and Vaccinology > Guann-Yi Yu > Periodical Articles > Item 3990099045/12750

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/12750

Title:	Zika virus NS3 protease pharmacophore anchor model and drug discovery
Authors:	Pathak, N;Kuo, YP;Chang, TY;Huang, CT;Hung, HC;Hsu, JTA;Yu, GY;Yang, JM
Contributors:	National Institute of Infectious Diseases and Vaccinology;Institute of Biotechnology and Pharmaceutical Research
Abstract:	Zika virus (ZIKV) of the flaviviridae family, is the cause of emerging infections characterized by fever, Guillain-Barré syndrome (GBS) in adults and microcephaly in newborns. There exists an urgent unmet clinical need for anti-ZIKV drugs for the treatment of infected individuals. In the current work, we aimed at the promising virus drug target, ZIKV NS3 protease and constructed a Pharmacophore Anchor (PA) model for the active site. The PA model reveals a total of 12 anchors (E, H, V) mapped across the active site subpockets. We further identified five of these anchors to be critical core anchors (CEH1, CH3, CH7, CV1, CV3) conserved across flaviviral proteases. The ZIKV protease PA model was then applied in anchor-enhanced virtual screening yielding 14 potential antiviral candidates, which were tested by in vitro assays. We discovered FDA drugs Asunaprevir and Simeprevir to have potent anti-ZIKV activities with EC50 values 4.7 µM and 0.4 µM, inhibiting the viral protease with IC50 values 6.0 µM and 2.6 µM respectively. Additionally, the PA model anchors aided in the exploration of inhibitor binding mechanisms. In conclusion, our PA model serves as a promising guide map for ZIKV protease targeted drug discovery and the identified ‘previr’ FDA drugs are promising for anti-ZIKV treatments.
Date:	2020-06-02
Relation:	Scientific Reports. 2020 Jun 2;10:Article number 8929.
Link to:	http://dx.doi.org/10.1038/s41598-020-65489-w
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2045-2322&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000560796300019
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85085689914
Appears in Collections:	[Guann-Yi Yu] Periodical Articles [John Tsu-An Hsu] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP85085689914.pdf		4513Kb	Adobe PDF	271	View/Open

Loading...